Physician profile
Alpha Banks
NPI 1780713156
$996.23
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $585 · 2020: $69.82 · 2021: $18.74 · 2022: $122 · 2023: $181 · 2024: $20.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $201.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $478.21 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $147.54 | 2019 | |
| Abbvie INC. | $101.36 | 2019-2020 | |
| Intercept Pharmaceuticals, INC. | $76.58 | 2019-2022 | |
| Braintree Laboratories, INC. | $45.08 | 2019-2023 | Sutab |
| Shionogi INC | $37.69 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.78 | 2019 | |
| Shire North American Group INC | $20.32 | 2019 | |
| Ferring Pharmaceuticals INC. | $17.60 | 2019 | |
| Ironwood Pharmaceuticals, INC | $15.54 | 2019 | |
| Boston Scientific Corporation | $11.72 | 2019 | |
| Allergan, INC. | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alpha Banks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.